IBC Policies
General
- UCLA Policy 992: Use of Biohazardous Materials and Recombinant or Synthetic Nucleic Acid Molecules in Research and Teaching Activities
- INSTITUTIONAL BIOSAFETY PLAN (revised December 2019)
- Committee Composition and Quorum Size (revised August 2014)
- Reporting Incidents Involving Biohazard Materials (revised July 2011, updated January 2022)
- Investigating Allegations of Noncompliance (approved July 2014, updated January 2022)
- Reporting Allegations of Noncompliance (approved July 2014, updated January 2022)
- IBC Visitor Policy (approved November 2016)
- Registration of Transgenic Animals (revised March 2019, updated January 2022)
- Genetically Modified Animals
Materials and Operations
- Use of Human and Nonhuman Primate Cells and Tissues (revised October 2015)
- Use of Open Flames in Biological Safety Cabinets (approved September 2008)
- Replication Competent Lentivirus Testing (approved June 2008)
- Use of Replication-Defective Adeno-Associated Viral Vectors in Rodents (approved November 2016)
- Use of Glass Pipettes in BSL-2 or Higher Laboratories (approved April 2017, revised June 2023)
- Transport of Animals Containing Biohazardous Materials (approved July 2018)
IBC Guidance Documents
- Guidelines for Working Safely with Zika Virus in the Laboratory (revised November 2016)
- IBC Requirements for Human Gene Transfer (HGT) Studies (approved March 2017, revised March 2022)
- Hazard Communication: CRISPR/Cas9 Technology (approved January 2016)
- UCLA Guidance on working with SARS-CoV-2 (approved March 2025)